CDK13 cooperates with CDK12 to control global RNA polymerase II processivity.

Saved in:
Bibliographic Details
Title: CDK13 cooperates with CDK12 to control global RNA polymerase II processivity.
Authors: Fan Z; The Peter MacCallum Cancer Centre, Melbourne, 3000 VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3052 VIC, Australia., Devlin JR; The Peter MacCallum Cancer Centre, Melbourne, 3000 VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3052 VIC, Australia., Hogg SJ; The Peter MacCallum Cancer Centre, Melbourne, 3000 VIC, Australia., Doyle MA; The Peter MacCallum Cancer Centre, Melbourne, 3000 VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3052 VIC, Australia., Harrison PF; Monash Biomedicine Discovery Institute, Monash University, Clayton, 3800 VIC, Australia.; Monash Bioinformatics Platform, Monash University, Clayton, 3800 VIC, Australia., Todorovski I; The Peter MacCallum Cancer Centre, Melbourne, 3000 VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3052 VIC, Australia., Cluse LA; The Peter MacCallum Cancer Centre, Melbourne, 3000 VIC, Australia., Knight DA; The Peter MacCallum Cancer Centre, Melbourne, 3000 VIC, Australia., Sandow JJ; Walter and Eliza Hall Institute of Medical Research, Parkville, 3052 VIC, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, 3052 VIC, Australia., Gregory G; The Peter MacCallum Cancer Centre, Melbourne, 3000 VIC, Australia., Fox A; The Peter MacCallum Cancer Centre, Melbourne, 3000 VIC, Australia., Beilharz TH; Monash Biomedicine Discovery Institute, Monash University, Clayton, 3800 VIC, Australia., Kwiatkowski N; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Scott NE; Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Parkville, 3052 VIC, Australia., Vidakovic AT; Mechanisms of Transcription Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Kelly GP; Bioinformatics and Biostatistics, The Francis Crick Institute, London NW1 1AT, UK., Svejstrup JQ; Mechanisms of Transcription Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Geyer M; Institute of Structural Biology, University of Bonn, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany., Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Vervoort SJ; The Peter MacCallum Cancer Centre, Melbourne, 3000 VIC, Australia. ricky.johnstone@petermac.org stephin.vervoort@petermac.org.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3052 VIC, Australia., Johnstone RW; The Peter MacCallum Cancer Centre, Melbourne, 3000 VIC, Australia. ricky.johnstone@petermac.org stephin.vervoort@petermac.org.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3052 VIC, Australia.
Source: Science advances [Sci Adv] 2020 Apr 29; Vol. 6 (18). Date of Electronic Publication: 2020 Apr 29 (Print Publication: 2020).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2375-2548
DOI:10.1126/sciadv.aaz5041